Bright Minds Biosciences Inc (DRUG)
Healthcare
Biotechnology
73.30 $
-1.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Bright Minds Biosciences Inc (DRUG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -8.7 million CAD. Tick rows to compare them in a chart.
All figures in millions of CAD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.0 | -0.3 | -7.3 | -14 | -7.0 | -1.9 | -8.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | |
| – | 0.2 | 0.9 | 0.9 | 1.2 | 0.8 | 3.2 | |
| 0.2 | 0.2 | 1.0 | 0.6 | – | – | – | |
| 0.0 | 0.0 | 0.3 | 0.7 | -0.9 | 0.0 | 0.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | |
| 0.1 | 1.0 | 26 | 5.2 | 2.2 | 0.8 | 86 | |
| 0.1 | 0.7 | 19 | -8.1 | -4.9 | -1.0 | 77 | |
| 0.0 | -0.3 | -7.3 | -14 | -7.0 | -1.9 | -8.7 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.